Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Vaccines
1.2.4 Checkpoint Inhibitors
1.2.5 Non-Specific Immunotherapy
1.3 Market by Application
1.3.1 Global Immunotherapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Oncology
1.3.3 Inflammation
1.3.4 Central Nervous System
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunotherapy Market Perspective (2018-2033)
2.2 Immunotherapy Growth Trends by Region
2.2.1 Global Immunotherapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Immunotherapy Historic Market Size by Region (2018-2023)
2.2.3 Immunotherapy Forecasted Market Size by Region (2024-2033)
2.3 Immunotherapy Market Dynamics
2.3.1 Immunotherapy Industry Trends
2.3.2 Immunotherapy Market Drivers
2.3.3 Immunotherapy Market Challenges
2.3.4 Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunotherapy Players by Revenue
3.1.1 Global Top Immunotherapy Players by Revenue (2018-2023)
3.1.2 Global Immunotherapy Revenue Market Share by Players (2018-2023)
3.2 Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunotherapy Revenue
3.4 Global Immunotherapy Market Concentration Ratio
3.4.1 Global Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Revenue in 2022
3.5 Immunotherapy Key Players Head office and Area Served
3.6 Key Players Immunotherapy Product Solution and Service
3.7 Date of Enter into Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapy Breakdown Data by Type
4.1 Global Immunotherapy Historic Market Size by Type (2018-2023)
4.2 Global Immunotherapy Forecasted Market Size by Type (2024-2033)
5 Immunotherapy Breakdown Data by Application
5.1 Global Immunotherapy Historic Market Size by Application (2018-2023)
5.2 Global Immunotherapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immunotherapy Market Size (2018-2033)
6.2 North America Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Immunotherapy Market Size by Country (2018-2023)
6.4 North America Immunotherapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunotherapy Market Size (2018-2033)
7.2 Europe Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Immunotherapy Market Size by Country (2018-2023)
7.4 Europe Immunotherapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunotherapy Market Size (2018-2033)
8.2 Asia-Pacific Immunotherapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Immunotherapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Immunotherapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunotherapy Market Size (2018-2033)
9.2 Latin America Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Immunotherapy Market Size by Country (2018-2023)
9.4 Latin America Immunotherapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunotherapy Market Size (2018-2033)
10.2 Middle East & Africa Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Immunotherapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Immunotherapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Immunotherapy Introduction
11.1.4 Abbvie Revenue in Immunotherapy Business (2018-2023)
11.1.5 Abbvie Recent Development
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Company Detail
11.2.2 Amgen, Inc. Business Overview
11.2.3 Amgen, Inc. Immunotherapy Introduction
11.2.4 Amgen, Inc. Revenue in Immunotherapy Business (2018-2023)
11.2.5 Amgen, Inc. Recent Development
11.3 Biogen
11.3.1 Biogen Company Detail
11.3.2 Biogen Business Overview
11.3.3 Biogen Immunotherapy Introduction
11.3.4 Biogen Revenue in Immunotherapy Business (2018-2023)
11.3.5 Biogen Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Immunotherapy Introduction
11.4.4 Bristol-Myers Squibb Revenue in Immunotherapy Business (2018-2023)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Immunotherapy Introduction
11.5.4 Celgene Revenue in Immunotherapy Business (2018-2023)
11.5.5 Celgene Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Immunotherapy Introduction
11.6.4 Johnson & Johnson Revenue in Immunotherapy Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Immunotherapy Introduction
11.7.4 Merck Revenue in Immunotherapy Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Immunotherapy Introduction
11.8.4 Novartis Revenue in Immunotherapy Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Immunotherapy Introduction
11.9.4 Pfizer Revenue in Immunotherapy Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Immunotherapy Introduction
11.10.4 Roche Revenue in Immunotherapy Business (2018-2023)
11.10.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immunotherapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Therapeutic Vaccines
Table 4. Key Players of Checkpoint Inhibitors
Table 5. Key Players of Non-Specific Immunotherapy
Table 6. Global Immunotherapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Immunotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Immunotherapy Market Share by Region (2018-2023)
Table 10. Global Immunotherapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Immunotherapy Market Share by Region (2024-2033)
Table 12. Immunotherapy Market Trends
Table 13. Immunotherapy Market Drivers
Table 14. Immunotherapy Market Challenges
Table 15. Immunotherapy Market Restraints
Table 16. Global Immunotherapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Immunotherapy Market Share by Players (2018-2023)
Table 18. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2022)
Table 19. Ranking of Global Top Immunotherapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Immunotherapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immunotherapy Product Solution and Service
Table 23. Date of Enter into Immunotherapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Immunotherapy Revenue Market Share by Type (2018-2023)
Table 27. Global Immunotherapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Immunotherapy Revenue Market Share by Type (2024-2033)
Table 29. Global Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Immunotherapy Revenue Market Share by Application (2018-2023)
Table 31. Global Immunotherapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Immunotherapy Revenue Market Share by Application (2024-2033)
Table 33. North America Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Immunotherapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Immunotherapy Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 48. Abbvie Company Detail
Table 49. Abbvie Business Overview
Table 50. Abbvie Immunotherapy Product
Table 51. Abbvie Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 52. Abbvie Recent Development
Table 53. Amgen, Inc. Company Detail
Table 54. Amgen, Inc. Business Overview
Table 55. Amgen, Inc. Immunotherapy Product
Table 56. Amgen, Inc. Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 57. Amgen, Inc. Recent Development
Table 58. Biogen Company Detail
Table 59. Biogen Business Overview
Table 60. Biogen Immunotherapy Product
Table 61. Biogen Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 62. Biogen Recent Development
Table 63. Bristol-Myers Squibb Company Detail
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Immunotherapy Product
Table 66. Bristol-Myers Squibb Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Celgene Company Detail
Table 69. Celgene Business Overview
Table 70. Celgene Immunotherapy Product
Table 71. Celgene Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 72. Celgene Recent Development
Table 73. Johnson & Johnson Company Detail
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Immunotherapy Product
Table 76. Johnson & Johnson Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. Merck Company Detail
Table 79. Merck Business Overview
Table 80. Merck Immunotherapy Product
Table 81. Merck Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Novartis Company Detail
Table 84. Novartis Business Overview
Table 85. Novartis Immunotherapy Product
Table 86. Novartis Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Pfizer Company Detail
Table 89. Pfizer Business Overview
Table 90. Pfizer Immunotherapy Product
Table 91. Pfizer Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Roche Company Detail
Table 94. Roche Business Overview
Table 95. Roche Immunotherapy Product
Table 96. Roche Revenue in Immunotherapy Business (2018-2023) & (US$ Million)
Table 97. Roche Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunotherapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Immunotherapy Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Antibodies Features
Figure 4. Therapeutic Vaccines Features
Figure 5. Checkpoint Inhibitors Features
Figure 6. Non-Specific Immunotherapy Features
Figure 7. Global Immunotherapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Immunotherapy Market Share by Application: 2022 VS 2033
Figure 9. Oncology Case Studies
Figure 10. Inflammation Case Studies
Figure 11. Central Nervous System Case Studies
Figure 12. Others Case Studies
Figure 13. Immunotherapy Report Years Considered
Figure 14. Global Immunotherapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Immunotherapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Immunotherapy Market Share by Region: 2022 VS 2033
Figure 17. Global Immunotherapy Market Share by Players in 2022
Figure 18. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Immunotherapy Revenue in 2022
Figure 20. North America Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Immunotherapy Market Share by Country (2018-2033)
Figure 22. United States Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Immunotherapy Market Share by Country (2018-2033)
Figure 26. Germany Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Immunotherapy Market Share by Region (2018-2033)
Figure 34. China Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Immunotherapy Market Share by Country (2018-2033)
Figure 42. Mexico Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Immunotherapy Market Share by Country (2018-2033)
Figure 46. Turkey Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Abbvie Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 49. Amgen, Inc. Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 50. Biogen Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 52. Celgene Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 55. Novartis Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 57. Roche Revenue Growth Rate in Immunotherapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed